Virtual Library

Start Your Search

  • WCLC 2013

    15th World Conference on Lung Cancer

    Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.

    Presentation Date(s):  
    • October 27 - 30, 2013
    • Total Presentations: 2517

Filter Results:

Show Only Available Presentations

  • +

    O03 - NSCLC - Targeted Therapies I

    • Type: Oral Abstract Session
    • Track: Medical Oncology
    • Presentations: 8
    • Moderators:J. Ross
    • Coordinates: 10/28/2013, 10:30 - 12:00, Bayside Auditorium B, Level 1
    • +

      O03.06 - First-In-Human Evaluation of CO-1686, an Irreversible, Highly, Selective Tyrosine Kinase Inhibitor of Mutations of EGFR (Activating and T790M)

      11:25 - 11:35  |  Author(s): J. Soria

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MO07 - NSCLC - Targeted Therapies II

    • Type: Mini Oral Abstract Session
    • Track: Medical Oncology
    • Presentations: 14
    • Moderators:T. John
    • Coordinates: 10/28/2013, 16:15 - 17:45, Bayside Auditorium B, Level 1
  • +

    MO08 - NSCLC - Early Stage

    • Type: Mini Oral Abstract Session
    • Track: Medical Oncology
    • Presentations: 12
    • Moderators:K. Nakagawa
    • Coordinates: 10/28/2013, 16:15 - 17:45, Bayside Gallery B, Level 1
    • +

      MO08.02 - Adjuvant pazopanib or placebo in resected stage I NSCLC patients: results of the NSCLC adjuvant randomized phase II trial (IFCT-0703) from the French collaborative Intergroup

      16:20 - 16:25  |  Author(s): B. Besse

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P2.11 - Poster Session 2 - NSCLC Novel Therapies

    • Type: Poster Session
    • Track: Medical Oncology
    • Presentations: 46
    • Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P2.11-004 - A Phase Ib, open label, dose escalation study of the safety and pharmacology of PI3-Kinase (PI3K) Inhibitor GDC 0941 in combination with either Paclitaxel (Pac) and Carboplatin (Carbo) with or without Bevacizumab (Bev), or Pemetrexed (Pem), Cisplatin (Cis), and Bev in patients with advanced Non–Small Cell Lung Cancer (NSCLC).

      09:30 - 09:30  |  Author(s): G.K. Dy

      • Abstract

      Loading...

  • +

    O17 - Anatomical Pathology I

    • Type: Oral Abstract Session
    • Track: Pathology
    • Presentations: 8
    • Moderators:K. Jones
    • Coordinates: 10/29/2013, 10:30 - 12:00, Bayside 105, Level 1
    • +

      O17.01 - Prognostic and predictive value of a new IASLC/ATS/ERS lung adenocarcinoma classification in a pooled analysis of four adjuvant chemotherapy trials: a LACE-Bio study

      10:30 - 10:40  |  Author(s): E.M. Brambilla

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MO18 - NSCLC - Targeted Therapies IV

    • Type: Mini Oral Abstract Session
    • Track: Medical Oncology
    • Presentations: 13
    • Moderators:L. Horn
    • Coordinates: 10/29/2013, 16:15 - 17:45, Bayside Auditorium B, Level 1
    • +

      MO18.01 - An analysis of the relationship of clinical activity to baseline EGFR status, PD-L1 expression and prior treatment history in patients with non-small cell lung cancer (NSCLC) following PD-L1 blockade with MPDL3280A (anti-PDL1)

      16:15 - 16:20  |  Author(s): L. Horn

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    O27 - Clinical Trials and Practice

    • Type: Oral Abstract Session
    • Track: Other Topics
    • Presentations: 8
    • Moderators:J.S. Lee
    • Coordinates: 10/29/2013, 16:15 - 17:45, Bayside Auditorium A, Level 1
    • +

      O27.07 - Molecular multidisciplinary tumor board (MMTB) for lung cancer patients: 2-year experience report

      17:20 - 17:30  |  Author(s): B. Besse

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P3.18 - Poster Session 3 - Pathology

    • Type: Poster Session
    • Track: Pathology
    • Presentations: 21
    • Coordinates: 10/30/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P3.18-018 - Results of upfront genomic testing in non-small cell lung cancer (NSCLC) patients (MSN study)

      09:30 - 09:30  |  Author(s): D. Planchard

      • Abstract

      Loading...

  • +

    MO19 - Lung Cancer Immunobiology

    • Type: Mini Oral Abstract Session
    • Track: Biology
    • Presentations: 13
    • Moderators:Y. Sekido
    • Coordinates: 10/30/2013, 10:30 - 12:00, Bayside 201 - 203, Level 2
    • +

      MO19.09 - Molecular correlates of PD-L1 status and predictive biomarkers in patients with non-small cell lung cancer (NSCLC) treated with the anti-PDL1 antibody MPDL3280A

      11:20 - 11:25  |  Author(s): S.N. Gettinger

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MO21 - Prognostic and Predictive Biomarkers V - EGFR

    • Type: Mini Oral Abstract Session
    • Track: Medical Oncology
    • Presentations: 12
    • Moderators:D.C. Lam
    • Coordinates: 10/30/2013, 10:30 - 12:00, Bayside Auditorium A, Level 1
    • +

      MO21.10 - Serial monitoring of plasma EGFR T790M levels and evaluation of EGFR mutational status in matched tissue and plasma from NSCLC patients treated with CO-1686

      11:25 - 11:30  |  Author(s): H.A. Wakelee

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.